Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 170

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 170
---

may not always conduct independent reviews of patents issued to third parties and such reviews, if conducted, may not identify all possible
infringements. Holders of certain patents may contact us and request we enter into license agreements for the underlying technology and
pay them royalties, which could be substantial. If we need to obtain a license to use any intellectual property, we may be unable to obtain
these licenses on favorable terms or at all or we may be required to make substantial royalty or other payments to use this intellectual
property. Litigation concerning patents, trade secret and proprietary rights can be time-consuming, expensive and unpredictable, and could
divert the attention of our management and other employees from our business operations. Patent applications in the United States and
elsewhere can be pending for many years before issuance, or unintentionally abandoned patents or applications can be revived, so there
may be applications of others now pending or recently revived patents of which we are unaware. Patent applications in the United States,
Europe and elsewhere are published approximately 18 months after the earliest filing for which priority is claimed, with such earliest
filing date being commonly referred to as the priority date. These applications that later result in issued patents, or the revival of
previously abandoned patents, may prevent, limit or otherwise interfere with our ability to develop and market our products. Third parties
may assert claims that we are employing their proprietary technology without authorization, including claims from competitors or from
non-practicing entities that have no relevant product revenue and against whom our own patent portfolio and in-licensed patents may have
no deterrent effect.

As we continue
to commercialize our technology and products in their current or updated forms, launch new technologies and products and enter new markets,
we expect competitors may claim that one or more of our technology or products infringe their intellectual property rights as a strategy
to impede our commercialization and entry into new markets. The large number of patent issuances, the rapid rate of new patent application
filings, the complexities of the technologies involved, and the uncertainty of litigation may increase the risk to our business and result
in business resources and management’s attention being diverted to patent litigation. An adverse ruling in a patent litigation could
subject us to significant liability, require us to seek licenses, and restrict our ability to commercialize our technology or manufacture
and sell our products. Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we
can because they have substantially greater resources.

Additionally,